Cannabis therapies are available for:
- Rheumatoid arthritis
- Multiple sclerosis (MS)
- Lyme Disease
- Thyroid Disease
- And Many More…
Immune Compromised Disorders
Many diseases stem from pathological bacteria or viruses that attack the immune system, as well as dysfunctions of the system that cause immune cells to attack health parts of the body. Remarkably, cannabinoids have been implicated in the therapeutic management of many immune-related conditions.
One of the most aggressive viruses that attack the immune system is the human immunodeficiency virus (HIV). It infiltrates and kills CD4 T cells, decreasing them to the point where the body cannot fight off even the most basic of infections. Unfortunately, not much research has been done on human cannabis use and HIV, although a study by Dr. Donald Abrams confirmed that smoked and oral cannabinoids do not seem to negatively impact immune metrics in HIV patients. Studies using animals and the related simian immunodeficiency virus (SIV) have illuminated great potential for tetrahydrocannabinol. A 2010 trial showed that chronic THC administration to SIV-infected animals resulted in lower plasma viral loads and reduced viral DNA and RNA. Next year, another study confirmed THC could decrease early mortality in infected animals.
Cannabis is generally an adaptogenic herb that can suppress or stimulate the immune system as needed. In the case of autoimmune conditions, mitigating overactive immune responses is critical. For example, Crohn’s disease is a form of inflammatory bowel disease that affects the gastrointestinal tract. CB1 receptors have been shown to provide protection against colonic inflammation, and targeting them is a promising strategy for treating a wide variety of inflammatory intestinal conditions. Given this observation, it is not surprising that a double-blind, placebo-controlled trial determined THC-rich cannabis could significantly alleviate Crohn’s symptoms to the point of remission.
Fibromyalgia is a very difficult to treat and poorly understand neurological condition which also impacts the immune system. Numerous observational studies and double-blind trials have confirmed cannabinoids can positively impact fibromyalgia symptoms. An extensive survey of 124 fibromyalgia patients reported THC significantly improved psychometric parameters and pain intensity in the majority of them. Two double-blind trials showed the synthetic cannabinoid nabilone could reduce pain and improve sleep. Furthermore, a survey by the National Pain Foundation found that 62% of respondents reported medicinal cannabis as “very effective” for their symptoms, compared to a maximum of 10% for conventional drugs.